UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000034205
Receipt No. R000038991
Scientific Title An investigator-initiated, multicenter, phase II study to determine the efficacy and safety of brentuximab vedotin in patients with relapsed or refractory CD30-positive cutaneous T-Cell lymphoma
Date of disclosure of the study information 2019/01/01
Last modified on 2018/09/20 08:44:15

No. Disposal Last modified on Item of update
1 Insert 2018/09/20 01:23:25
2 Update 2018/09/20 08:44:15 Interventions/Control_1


Contact us.